Names and Identifiers

• • glaucamine
  • (6α)-2,3-Dimethoxy-16-methyl-10,11-[methylenebis(oxy)]rheadan-8α-ol
  • 1,3-Dioxolo[7,8][2]benzopyrano[3,4-a][3]benzazepin-14-ol,5b,6,7,8,12b,14-hexahydro-10,11-dimethoxy-6-methyl-, (5bR,12bS,14R)-
  • 1,3-Dioxolo[7,8][2]benzopyrano[3,4-a][3]benzazepin-14-ol,5b,6,7,8,12b,14-hexahydro-10,11-dimethoxy-6-methyl-, [5bR-(5ba,12bb,14b)]-
  • Glaucamine(7CI)
  • Rheadan-8-ol, 2,3-dimethoxy-16-methyl-10,11-[methylenebis(oxy)]-, (6a,8a)-
  • (5bR,12bS,14R)-5b,6,7,8,12b,14-Hexahydro-10,11-dimethoxy-6-methyl-1,3-dioxolo[7,8][2]benzopyrano[3,4-a][3]benzazepin-14-ol
  • DTXSID001104489
  • 2255-44-9
  • XYWRZQQANNOTTD-UHFFFAOYSA-N
  • 16,17-dimethoxy-22-methyl-6,8,12-trioxa-22-azapentacyclo[11.9.0.0^{2,10}.0^{5,9}.0^{14,19}]docosa-2,4,9,14(19),15,17-hexaen-11-ol
  • 10,11-Dimethoxy-6-methyl-5b,6,7,8,12b,14-hexahydro[1,3]dioxolo[4',5':7,8]isochromeno[3,4-a][3]benzazepin-14-ol #
  • 2,3-Dimethoxy-16-methyl-10,11-[methylenebis(oxy)]rheadan-8-ol, 9CI
  • Rheadan-8-ol, 2,3-dimethoxy-16-methyl-10,11-[methylenebis(oxy)]-, (6.alpha.,8.alpha.)-
  • Alkaloid R-L
  • 1,3-Dioxolo[7,8][2]benzopyrano[3,4-a][3]benzazepine, rheadan-8-ol deriv.
  • +expand
• • Inchi： 1S/C21H23NO6/c1-22-7-6-11-8-15(24-2)16(25-3)9-13(11)19-18(22)12-4-5-14-20(27-10-26-14)17(12)21(23)28-19/h4-5,8-9,18-19,21,23H,6-7,10H2,1-3H3/t18-,19+,21-/m1/s1
  • InChI Key： XYWRZQQANNOTTD-SVFBPWRDSA-N
  • SMILES： O1[C@H](C2C3=C(C=CC=2[C@@H]2[C@@H]1C1C=C(C(=CC=1CCN2C)OC)OC)OCO3)O

Computed Properties